Transarterial chemoembolization for hepatocellular carcinoma: A review of techniques

Table 1 Summary of key prospective trials and retrospective studies for the treatment of hepatocellular carcinoma

	Ref.	Year	Analysis	No. of patients	Objective response (%)	Overall survival (%)
						1 yr	2 yr	3 yr
cTACE
	Llovet et al[7]	2002	Prospective	40	35 (at 6 mo)	82	63	29
	Lo et al[8]	2002	Prospective	40	39 (at 3 mo)	57	31	26
	Takayasu et al[10]	2006	Prospective	8510	NA	82	63	47
DEB-TACE
	Lammer et al[52]	2010	Prospective	102	51.6 (at 6 mo)	NA	NA	NA
	Sacco et al[54]	2011	Prospective	33	100 (at 1 mo)	NA	86.8	NA
	Song et al[57]	2012	Retrospective	60	81.6 (at 3 mo)	88	NA	NA
	Wiggermann et al[58]	2011	Retrospective	22	22.7 (at 8 mo)	70	NA	NA

TACE: Transcatheter arterial chemoembolization; cTACE: Conventional TACE; DEB: Drug-eluting bead; NA: Not available.